Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology (CTC-CEC-ADN)

Inclusion Criteria:

• 18 years old or more
• Performance status from 0 to 4
• Patient treated followed for histologically confirmed solid tumor type of any of these localization : breast, prostate, uterus, ovary, colon, lung, head and neck, melanoma.
• Informed consent form signed.

Exclusion Criteria:

• Patient with history of other invasive cancer within 5 years.
• Patient treated for any non-invasive cancer
• Patient individually deprived of liberty or placed under the authority of a tutor
• Geographical condition potentially preventing compliance with the study protocol.